156 related articles for article (PubMed ID: 31116482)
1. Impact of smoking cessation on clinical outcomes in patients with head and neck squamous cell carcinoma receiving curative chemoradiotherapy: A prospective study.
Chen JL; Shen CW; Wang CC; Huang YS; Chen JP; Chiang CH; Lin YL; Kuo SH; Wang CW
Head Neck; 2019 Sep; 41(9):3201-3210. PubMed ID: 31116482
[TBL] [Abstract][Full Text] [Related]
2. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Chen JL; Chang CC; Huang YS; Kuo HY; Chen TY; Wang CW; Kuo SH; Lin YL
PLoS One; 2018; 13(8):e0202224. PubMed ID: 30096190
[TBL] [Abstract][Full Text] [Related]
3. High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chang CL; Yuan KS; Wu SY
Head Neck; 2017 Jul; 39(7):1364-1370. PubMed ID: 28370614
[TBL] [Abstract][Full Text] [Related]
4. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Okano S; Enokida T; Onoe T; Ota Y; Motegi A; Zenda S; Akimoto T; Tahara M
Int J Clin Oncol; 2019 Jul; 24(7):789-797. PubMed ID: 30796560
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
[TBL] [Abstract][Full Text] [Related]
6. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J
Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693
[TBL] [Abstract][Full Text] [Related]
7. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
[TBL] [Abstract][Full Text] [Related]
8. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy.
Bentahila R; Giraud P; Decazes P; Kreps S; Nay P; Chatain A; Fabiano E; Durdux C
Cancer Med; 2023 Feb; 12(4):4170-4183. PubMed ID: 36263581
[TBL] [Abstract][Full Text] [Related]
9. Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
Nagasaka M; Zaki M; Issa M; Kim H; Abrams J; Sukari A
Laryngoscope; 2017 Oct; 127(10):2260-2264. PubMed ID: 28271529
[TBL] [Abstract][Full Text] [Related]
10. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
[TBL] [Abstract][Full Text] [Related]
12. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.
Hinther A; Samson N; Lau H; Quon H; Banerjee R; Lysack JT; Grendarova P; Matthews TW; Randall DR
Laryngoscope; 2020 Mar; 130(3):597-602. PubMed ID: 31260128
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
14. Persistent Tobacco Use After Treatment for Head and Neck Cancer.
Van Heest T; Rubin N; Khariwala SS
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):597-603. PubMed ID: 35551592
[TBL] [Abstract][Full Text] [Related]
15. Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma.
Jensen KH; Vogelius IR; Bernsdorf M; Gothelf A; Kristensen CA; Maare C; Andersen E; Specht L; Friborg J
Radiother Oncol; 2022 Jun; 171():1-6. PubMed ID: 35395275
[TBL] [Abstract][Full Text] [Related]
16. JAVELIN Head and Neck 100: a Phase III trial of avelumab and chemoradiation for locally advanced head and neck cancer.
Yu Y; Lee NY
Future Oncol; 2019 Mar; 15(7):687-694. PubMed ID: 30461306
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G
Cancer; 2023 Mar; 129(6):867-877. PubMed ID: 36653915
[TBL] [Abstract][Full Text] [Related]
18. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma.
Guven DC; Erul E; Yilmaz F; Yasar S; Yildirim HC; Ercan F; Kaygusuz Y; Cayiroz K; Ucdal MT; Yesil F; Yazici G; Cengiz M; Gullu I; Aksoy S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2471-2478. PubMed ID: 36565325
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection.
Boros A; Blanchard P; Dade A; Gorphe P; Breuskin I; Even C; Nguyen F; Deutsch E; Bidault F; Janot F; Temam S; Mirghani H; Tao Y
Laryngoscope; 2021 Mar; 131(3):E846-E850. PubMed ID: 32833260
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
Mohamed A; Twardy B; Zordok MA; Ashraf K; Alkhoder A; Schrapp K; Steuer C; Chen Z; Pakkala S; Pillai R; Trad Wadsworth J; Higgins K; Beitler JJ; Ramalingam SS; Owonikoko TK; Khuri FR; Shin DM; Behera M; Saba NF
Head Neck; 2019 May; 41(5):1490-1498. PubMed ID: 30835900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
